These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7509626)

  • 1. Chromosome 10 allelic loss in malignant melanoma.
    Isshiki K; Elder DE; Guerry D; Linnenbach AJ
    Genes Chromosomes Cancer; 1993 Nov; 8(3):178-84. PubMed ID: 7509626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma.
    Millikin D; Meese E; Vogelstein B; Witkowski C; Trent J
    Cancer Res; 1991 Oct; 51(20):5449-53. PubMed ID: 1680551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 9 deletion in sporadic and familial melanomas in vivo.
    Isshiki K; Seng BA; Elder DE; Guerry D; Linnenbach AJ
    Oncogene; 1994 Jun; 9(6):1649-53. PubMed ID: 8183559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 17 allelic loss and NF1-GRD mutations do not play a significant role as molecular mechanisms leading to melanoma tumorigenesis.
    Gómez L; Rubio MP; Martin MT; Vázquez JJ; Idoate M; Pastorfide G; Pestaña A; Seizinger BR; Barnhill RL; Castresana JS
    J Invest Dermatol; 1996 Mar; 106(3):432-6. PubMed ID: 8648172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity in sporadic primary cutaneous melanoma.
    Healy E; Rehman I; Angus B; Rees JL
    Genes Chromosomes Cancer; 1995 Feb; 12(2):152-6. PubMed ID: 7535089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion mapping of chromosome 10 in human glioma.
    Sonoda Y; Murakami Y; Tominaga T; Kayama T; Yoshimoto T; Sekiya T
    Jpn J Cancer Res; 1996 Apr; 87(4):363-7. PubMed ID: 8641967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion mapping of chromosome 11 in carcinoma of the bladder.
    Shaw ME; Knowles MA
    Genes Chromosomes Cancer; 1995 May; 13(1):1-8. PubMed ID: 7541638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression.
    Herbst RA; Weiss J; Ehnis A; Cavenee WK; Arden KC
    Cancer Res; 1994 Jun; 54(12):3111-4. PubMed ID: 8205526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple tandem repeat allelic deletions confirm the preferential loss of distal chromosome 6q in melanoma.
    Walker GJ; Palmer JM; Walters MK; Nancarrow DJ; Parsons PG; Hayward NK
    Int J Cancer; 1994 Jul; 58(2):203-6. PubMed ID: 8026882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas.
    Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G
    Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay.
    Linnenbach AJ; Pressler LB; Seng BA; Kimmel BS; Tomaszewski JE; Malkowicz SB
    Hum Mol Genet; 1993 Sep; 2(9):1407-11. PubMed ID: 7902161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma.
    Cross NA; Ganesh A; Parpia M; Murray AK; Rennie IG; Sisley K
    Eye (Lond); 2006 Apr; 20(4):476-81. PubMed ID: 15920570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p.
    Jones MH; Koi S; Fujimoto I; Hasumi K; Kato K; Nakamura Y
    Genes Chromosomes Cancer; 1994 Feb; 9(2):119-23. PubMed ID: 7513541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas.
    Park SY; Kang YS; Kim BG; Lee SH; Lee ED; Lee KH; Park KB; Lee JH
    Cancer Genet Cytogenet; 1995 Jan; 79(1):74-8. PubMed ID: 7850756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance.
    MacGrogan D; Levy A; Bostwick D; Wagner M; Wells D; Bookstein R
    Genes Chromosomes Cancer; 1994 Jul; 10(3):151-9. PubMed ID: 7522037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of allelic deletions within melanoma metastases.
    Bogdan I; Xin H; Burg G; Böni R
    Melanoma Res; 2001 Aug; 11(4):349-54. PubMed ID: 11479423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
    Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
    Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelotyping of follicular thyroid tumors.
    Zedenius J; Wallin G; Svensson A; Grimelius L; Höög A; Lundell G; Bäckdahl M; Larsson C
    Hum Genet; 1995 Jul; 96(1):27-32. PubMed ID: 7607650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic model of melanoma tumorigenesis based on allelic losses.
    Walker GJ; Palmer JM; Walters MK; Hayward NK
    Genes Chromosomes Cancer; 1995 Feb; 12(2):134-41. PubMed ID: 7535086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.